151 related articles for article (PubMed ID: 17628494)
1. Evaluation of human nasal RPMI 2650 cells grown at an air-liquid interface as a model for nasal drug transport studies.
Bai S; Yang T; Abbruscato TJ; Ahsan F
J Pharm Sci; 2008 Mar; 97(3):1165-78. PubMed ID: 17628494
[TBL] [Abstract][Full Text] [Related]
2. Rhinovirus infection-induced alteration of tight junction and adherens junction components in human nasal epithelial cells.
Yeo NK; Jang YJ
Laryngoscope; 2010 Feb; 120(2):346-52. PubMed ID: 20013846
[TBL] [Abstract][Full Text] [Related]
3. Serially passaged human nasal epithelial cell monolayer for in vitro drug transport studies.
Yoo JW; Kim YS; Lee SH; Lee MK; Roh HJ; Jhun BH; Lee CH; Kim DD
Pharm Res; 2003 Oct; 20(10):1690-6. PubMed ID: 14620527
[TBL] [Abstract][Full Text] [Related]
4. The cell line NCl-H441 is a useful in vitro model for transport studies of human distal lung epithelial barrier.
Salomon JJ; Muchitsch VE; Gausterer JC; Schwagerus E; Huwer H; Daum N; Lehr CM; Ehrhardt C
Mol Pharm; 2014 Mar; 11(3):995-1006. PubMed ID: 24524365
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a confluent monolayer model with human primary trophoblast cells: novel insights into placental glucose transport.
Huang X; Lüthi M; Ontsouka EC; Kallol S; Baumann MU; Surbek DV; Albrecht C
Mol Hum Reprod; 2016 Jun; 22(6):442-56. PubMed ID: 26931579
[TBL] [Abstract][Full Text] [Related]
6. The characterization of the human nasal epithelial cell line RPMI 2650 under different culture conditions and their optimization for an appropriate in vitro nasal model.
Kreft ME; Jerman UD; Lasič E; Lanišnik Rižner T; Hevir-Kene N; Peternel L; Kristan K
Pharm Res; 2015 Feb; 32(2):665-79. PubMed ID: 25145337
[TBL] [Abstract][Full Text] [Related]
7. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
[TBL] [Abstract][Full Text] [Related]
8. Comparison of RPMI 2650 cell layers and excised sheep nasal epithelial tissues in terms of nasal drug delivery and immunocytochemistry properties.
Gerber W; Svitina H; Steyn D; Peterson B; Kotzé A; Weldon C; Hamman JH
J Pharmacol Toxicol Methods; 2022; 113():107131. PubMed ID: 34699972
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of bEnd5 cell line as an in vitro model for the blood-brain barrier under normal and hypoxic/aglycemic conditions.
Yang T; Roder KE; Abbruscato TJ
J Pharm Sci; 2007 Dec; 96(12):3196-213. PubMed ID: 17828743
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an in vitro brain barrier epithelial transport system for pharmacological and toxicological study.
Shi LZ; Zheng W
Brain Res; 2005 Sep; 1057(1-2):37-48. PubMed ID: 16126179
[TBL] [Abstract][Full Text] [Related]
11. Characterization of critical parameters using an air-liquid interface model with RPMI 2650 cells for permeability studies of small molecules.
Barlang LA; Weinbender K; Merkel OM; Popp A
Drug Deliv Transl Res; 2024 Jun; 14(6):1601-1615. PubMed ID: 37978162
[TBL] [Abstract][Full Text] [Related]
12. RPMI 2650 epithelial model and three-dimensional reconstructed human nasal mucosa as in vitro models for nasal permeation studies.
Wengst A; Reichl S
Eur J Pharm Biopharm; 2010 Feb; 74(2):290-7. PubMed ID: 19733661
[TBL] [Abstract][Full Text] [Related]
13. The NCI-N87 cell line as a gastric epithelial barrier model for drug permeability assay.
Lemieux M; Bouchard F; Gosselin P; Paquin J; Mateescu MA
Biochem Biophys Res Commun; 2011 Sep; 412(3):429-34. PubMed ID: 21821011
[TBL] [Abstract][Full Text] [Related]
14. The characterization of the human cell line Calu-3 under different culture conditions and its use as an optimized in vitro model to investigate bronchial epithelial function.
Kreft ME; Jerman UD; Lasič E; Hevir-Kene N; Rižner TL; Peternel L; Kristan K
Eur J Pharm Sci; 2015 Mar; 69():1-9. PubMed ID: 25555374
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of layers of the rat airway epithelial cell line RL-65 for permeability screening of inhaled drug candidates.
Hutter V; Hilgendorf C; Cooper A; Zann V; Pritchard DI; Bosquillon C
Eur J Pharm Sci; 2012 Sep; 47(2):481-9. PubMed ID: 22820031
[TBL] [Abstract][Full Text] [Related]
16. Permeability characteristics of novel mydriatic agents using an in vitro cell culture model that utilizes SIRC rabbit corneal cells.
Goskonda VR; Khan MA; Hutak CM; Reddy IK
J Pharm Sci; 1999 Feb; 88(2):180-4. PubMed ID: 9950635
[TBL] [Abstract][Full Text] [Related]
17. Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?
Mercier C; Perek N; Delavenne X
Eur J Drug Metab Pharmacokinet; 2018 Feb; 43(1):13-24. PubMed ID: 28688000
[TBL] [Abstract][Full Text] [Related]
18. Formation of tight monolayers of guinea pig airway epithelial cells cultured in an air-interface: bioelectric properties.
Robison TW; Dorio RJ; Kim KJ
Biotechniques; 1993 Sep; 15(3):468-73. PubMed ID: 8217160
[TBL] [Abstract][Full Text] [Related]
19. Nasal polyps and middle turbinates epithelial cells sensitivity to amphotericin B.
Jornot L; Rochat T; Lacroix JS
Rhinology; 2003 Dec; 41(4):201-5. PubMed ID: 14750346
[TBL] [Abstract][Full Text] [Related]
20. A collagen IV matrix is required for guinea pig gastric epithelial cell monolayers to provide an optimal model of the stomach surface for biopharmaceutical screening.
Kavvada KM; Murray JG; Moore VA; Coombes AG; Hanson PJ
J Biomol Screen; 2005 Aug; 10(5):495-507. PubMed ID: 16093559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
